NCT07742137

Brief Summary

This pilot study evaluates the feasibility, safety, and acceptability of an immersive virtual reality (VR) intervention designed to promote psychological well-being in older adults living in a long-term care facility. The study examines whether an eight-session VR program can be delivered safely and comfortably, whether participants tolerate and engage with the sessions, and whether the intervention shows preliminary signals of benefit in emotional well-being and subjective experience of presence. The results will inform the design and implementation of a larger, ongoing study using the same protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

July 28, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

Virtual Reality ExposureOlder AdultsLong-Term CareResidential FacilitiesPsychological Well-BeingImmersive Virtual RealityAvatar-Based InteractionEudaimonic Well-BeingRyff's ModelDignity-by-DesignInstitutionalized Older AdultsFeasibility StudyAcceptability StudyPilot Trial

Outcome Measures

Primary Outcomes (4)

  • Recruitment Rate

    Recruitment rate is defined as the proportion of eligible participants who enroll in the study during the recruitment period.

    At the end of the recruitment period (March 13, 2026).

  • Retention Rate

    Retention rate is defined as the proportion of enrolled participants who complete all scheduled assessments and sessions during the 4-week intervention period.

    From enrollment through completion of the 4-week intervention period.

  • Adverse Events

    Adverse events are monitored throughout the intervention period and recorded after each session, including discomfort, cybersickness, or any unexpected negative reactions.

    From the first session through the final session of the 4-week intervention period.

  • Acceptability (NPT-ES)

    Acceptability is assessed after each session using the adapted Non-Pharmacological Therapy Experience Scale (NPT-ES), which evaluates perceived usefulness, comfort, satisfaction, and willingness to continue the activity.

    Immediately after each session during the 4-week intervention period.

Secondary Outcomes (3)

  • Psychological Well-Being (Ryff Scales)

    From baseline assessment before starting the intervention through intermediate session assessments during the 4-week program and the post-intervention assessment at 4 weeks.

  • Sense of Presence (Presence Questionnaire)

    Immediately after each immersion session during the 4-week intervention period.

  • Emotional Reactions (Session Questionnaire)

    Immediately after each immersion session during the 4-week intervention period.

Study Arms (3)

Active IVR

EXPERIMENTAL

Participants complete the full REVI protocol, consisting of eight individually guided immersive virtual reality sessions delivered twice weekly over four weeks. Sessions include structured interaction with immersive virtual environments, guided experiential tasks, and presence-enhancing activities aligned with the psychological well-being model.

Behavioral: Active IVR

Passive IVR

EXPERIMENTAL

Participants complete eight immersive virtual reality sessions delivered twice weekly over four weeks. Sessions consist of passive exposure to immersive virtual environments without guided experiential tasks or structured interaction. Participants view the VR scenarios through Meta Quest 2 headsets while remaining seated and without engaging in presence-enhancing activities.

Behavioral: Passive IVR

Control

NO INTERVENTION

Participants do not receive any immersive virtual reality sessions. They complete the baseline and post-intervention assessments and join the study schedule at the same time points as the IVR groups to complete the inter-session evaluations appropriate for their condition. Participants receive usual care within the long-term care facility.

Interventions

Active IVRBEHAVIORAL

Participants complete eight individually guided immersive virtual reality sessions delivered twice weekly over four weeks. Sessions include structured interaction with immersive virtual environments, guided experiential tasks, and presence-enhancing activities aligned with the psychological well-being model.

Active IVR
Passive IVRBEHAVIORAL

Participants complete eight immersive virtual reality sessions delivered twice weekly over four weeks. Sessions consist of passive exposure to immersive virtual environments without guided experiential tasks or structured interaction. Participants view the VR scenarios while remaining seated and without engaging in presence-enhancing activities.

Passive IVR

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Residents of long-term care facilities.
  • Age 65 years or older.
  • Full functional independence (Barthel Index = 100).
  • Adequate balance and gait to safely participate in VR sessions (Berg Balance Scale \> 45).
  • Absence of significant cognitive impairment (MMSE ≥ 25 or CAMCOG-R ≥ 80).
  • Absence of clinically significant depressive symptoms (GDS-SF ≤ 5).
  • No prior experience with immersive virtual reality.
  • Able to provide informed consent or have a legal representative who can do so.
  • Able to remain seated for approximately 20 minutes per session.
  • Willing to participate in eight VR sessions over four weeks.

You may not qualify if:

  • Cognitive impairment that prevents understanding instructions or interacting with VR content.
  • Balance or gait limitations judged by clinical staff to pose a safety risk during VR use.
  • Medical or neurological conditions that contraindicate VR exposure (e.g., uncontrolled epilepsy, severe motion sickness).
  • Acute medical instability or conditions requiring urgent clinical intervention.
  • Any condition judged by clinical staff to pose a safety risk during VR immersion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Residencia San Juan de Dios

Seville, Spain

Location

Related Publications (1)

  • Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x.

    PMID: 15189396BACKGROUND

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Only the investigator responsible for assigning participants to the three study groups was masked to participant identity during allocation. No other study personnel, participants, or outcome assessors were masked.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study uses a three-arm parallel design in which participants are allocated to one of three conditions (Active IVR, Passive IVR, or Control). All groups follow a matched assessment timeline, although only the IVR groups complete session-based measures (e.g., NPT-ES, presence, qualitative feedback). The Control group completes baseline and post-intervention assessments on the same schedule but does not undergo IVR sessions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychology, Principal Investigator

Study Record Dates

First Submitted

July 28, 2026

First Posted

August 3, 2026

Study Start

March 16, 2026

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. The sample size is small and the data collected include sensitive information from older adults residing in long-term care facilities, making full de-identification insufficient to ensure participant privacy. No repository or mechanism for IPD sharing is planned.

Locations